EGFR and infection: Further analysis of EGFR-mediated cascade proteins at varying concentrations of vandetanib (ranging from 20 to 60 μM) during MOI 0.1 RSV infection for 16 h post-infection revealed a significant decrease in the expression of RSV-NP with vandetanib treatment (60 μM) (Figure 3C).